ARMISTICE CAPITAL, LLC - 31 Dec 2024 SCHEDULE 13G/A Report for AIM ImmunoTech Inc. Common Stock, par value $0.001 per share (AIMI)

Filing Manager: ARMISTICE CAPITAL, LLC
Reporting Manager: Armistice Capital, LLC
Security: AIM ImmunoTech Inc. Common Stock, par value $0.001 per share
Symbol: AIMI
Shares outstanding: 67,129,058 shares
Disclosed Ownership: 3,349,740 shares
Ownership: 5%
Form type: SCHEDULE 13G/A
Filing time: 14 Feb 2025, 16:55:37 UTC
Date of event: 31 Dec 2024
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Armistice Capital, LLC	5%	3,349,740	0	3,349,740	/s/ Steven Boyd	Steven Boyd - Managing Member
Steven Boyd	5%	3,349,740	0	3,349,740	/s/ Steven Boyd	Steven Boyd